Inogen Inc. Files 8-K for Financial Results Disclosure
Ticker: INGN · Form: 8-K · Filed: Feb 27, 2024 · CIK: 1294133
| Field | Detail |
|---|---|
| Company | Inogen Inc (INGN) |
| Form Type | 8-K |
| Filed Date | Feb 27, 2024 |
| Risk Level | low |
| Pages | 2 |
| Reading Time | 2 min |
| Key Dollar Amounts | $0.001 |
| Sentiment | neutral |
Sentiment: neutral
Topics: earnings, financial-report, 8-K, disclosure
TL;DR
Inogen just filed a standard 8-K to report its financial results, details to follow.
AI Summary
Inogen Inc. filed a Form 8-K on February 27, 2024, to report on its "Results of Operations and Financial Condition" and to include "Financial Statements and Exhibits." This filing, with CIK 0001294133, indicates the company is disclosing its latest financial performance as required by the Securities Exchange Act of 1934.
Why It Matters
This routine 8-K filing signals Inogen Inc.'s disclosure of its latest financial performance, providing investors with crucial information to assess the company's health and future prospects.
Risk Assessment
Risk Level: low — This 8-K is a standard disclosure of financial results, not indicating any immediate unusual risk from the filing itself.
Key Players & Entities
- Inogen Inc. (company) — Registrant
- February 27, 2024 (date) — Date of earliest event reported
- Delaware (location) — State of Incorporation
- 0001294133 (identifier) — Central Index Key (CIK)
FAQ
What type of SEC filing is this document?
This document is a Form 8-K, which is a Current Report filed pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934.
What is the earliest event reported date in this filing?
The earliest event reported date in this filing is February 27, 2024.
What is the full legal name of the registrant company?
The exact name of the Registrant as specified in its Charter is INOGEN, INC.
What specific items are being reported in this 8-K?
The 8-K reports on "Results of Operations and Financial Condition" and "Financial Statements and Exhibits."
What is Inogen Inc.'s business address?
Inogen Inc.'s business address is 859 Ward Drive, Goleta, California, 93111.
Filing Stats: 510 words · 2 min read · ~2 pages · Grade level 11 · Accepted 2024-02-27 16:08:33
Key Financial Figures
- $0.001 — nge on which registered Common Stock, $0.001 par value INGN The Nasdaq Stock Mar
Filing Documents
- ingn-20240227.htm (8-K) — 39KB
- ingn-ex99_1.htm (EX-99.1) — 675KB
- img132417817_0.jpg (GRAPHIC) — 3KB
- 0000950170-24-021113.txt ( ) — 852KB
- ingn-20240227.xsd (EX-101.SCH) — 23KB
- ingn-20240227_htm.xml (XML) — 4KB
02 Results of Operations and Financial Condition
Item 2.02 Results of Operations and Financial Condition. On February 27, 2024, Inogen, Inc. (the "Company") issued a press release reporting its financial results for the fourth quarter and the full year ended December 31, 2023. A copy of the press release is furnished herewith as Exhibit 99.1 to this Current Report on Form 8-K. The information furnished in this Current Report under Item 2.02 and the exhibit attached hereto shall not be deemed "filed" for purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the "Exchange Act"), or incorporated by reference in any filing under the Securities Act of 1933, as amended (the "Securities Act"), or the Exchange Act, except as shall be expressly set forth by specific reference in such a filing.
01 Financial Statements and Exhibits
Item 9.01 Financial Statements and Exhibits. (d) Exhibits Exhibit Description 99.1 Press Release dated February 27, 2024. 104 The cover page of this Current Report on Form 8-K, formatted in Inline XBRL.
SIGNATURES
SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized. INOGEN, INC. Date: February 27, 2024 By: /s/ Michael K. Sergesketter Michael K. Sergesketter Executive Vice President Chief Financial Officer Treasurer (Principal Accounting and Financial Officer)